Multisystem involvement associated with AL amyloidosis: a case report
Digital Diagnostics · 2026-09-17 · 7 (3) · 411-422
DOI: 10.17816/dd707163 ↗Abstract
Amyloid light-chain amyloidosis is a life-threatening systemic disorder; delayed diagnosis and treatment significantly impair patient quality of life and life expectancy. This case report presents a long-standing chronic kidney disease and arterial hypotension. Focused echocardiographic evaluation targeting the “red flags” of amyloidosis (a combination of left ventricular hypertrophy ≥ 12 mm and diastolic dysfunction) accompanied by gadolinium-enhanced cardiac magnetic resonance imaging, revealed findings characteristic of amyloid cardiomyopathy. Laboratory testing revealed abnormal production of λ light chains and ruled out multiple myeloma. Histological examination revealed multiorgan amyloid protein deposition sites in the gastrointestinal mucosa and renal parenchyma. The AL amyloidosis diagnosis was established based on these findings, enabling prompt initiation of daratumumab to suppress clonal light chain secretion and reduce amyloid protein production, which is essential for preserving duration and quality of life. This case highlights the need for comprehensive diagnostic evaluation in patients presenting with concurrent chronic kidney disease and severe myocardial hypertrophy. Integrating imaging “red flags” into routine clinical workflows alongside multimodal diagnostic algorithms enhances AL amyloidosis detection and positively impacts the disease trajectory.
EUVIMED